Digoxin and Amyloidosis - senile - a phase IV clinical study of FDA data

Summary:

Amyloidosis - senile is reported as a side effect among people who take Digoxin (digoxin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Omeprazole, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Amyloidosis - senile when taking Digoxin. It is created by eHealthMe based on reports of 92,292 people who have side effects when taking Digoxin from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Amyloidosis - senile?

Amyloidosis - senile (common form of amyloidosis in very old people, usually mild and limited to the heart) is found to be associated with 227 drugs and 386 conditions by eHealthMe. Check the latest studies of Amyloidosis - senile.

On Jul, 11, 2026

92,292 people reported to have side effects when taking Digoxin.
Among them, 25 people (0.03%) have Amyloidosis - senile.

Could Digoxin cause Amyloidosis - senile?

Among these 25 people:

How long have people been on Digoxin when they have Amyloidosis - senile? *

What is the gender of people who have Amyloidosis - senile when taking Digoxin? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Amyloidosis - senile when taking Digoxin? *

What are other drugs people take besides Digoxin? *

What are other side effects people have besides Amyloidosis - senile? *

Cardiac Failure: 8 people, 32.00%
Dyspnea (difficult or laboured breathing): 5 people, 20.00%
Cardiac Arrest: 4 people, 16.00%
Restrictive Cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility): 3 people, 12.00%
Renal Impairment (severely reduced kidney function): 3 people, 12.00%
Oedema (fluid collection in tissue): 3 people, 12.00%
Cardiac Failure Congestive: 3 people, 12.00%
Back Pain: 3 people, 12.00%
Atrial Tachycardia (rhythm disturbance that arises in the atria): 3 people, 12.00%
Post Procedural Haemorrhage (post procedural bleeding): 3 people, 12.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 16.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 12.00%
Gout (uric acid crystals building up in the body): 3 people, 12.00%
Back Pain: 3 people, 12.00%
Breast Cancer: 3 people, 12.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 8.00%
Cardiac Failure: 2 people, 8.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 8.00%
Lacrimal Cyst (cyst of lacrimal gland of eye): 2 people, 8.00%
Pain: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and have Amyloidosis - senile?

- Check whether Amyloidosis - senile is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Digoxin:

Digoxin (93,740 reports)

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Amyloidosis - senile:

Amyloidosis - senile (227 drugs)

Browse all the conditions that are associated with Amyloidosis - senile:

Amyloidosis - senile (386 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Digoxin) and Digoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.